Cargando…

Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records

BACKGROUND: Multimorbidity presents an increasingly common problem in older population, and is tightly related to polypharmacy, i.e., concurrent use of multiple medications by one individual. Detecting polypharmacy from drug prescription records is not only related to multimorbidity, but can also po...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocbek, Simon, Kocbek, Primoz, Stozer, Andraz, Zupanic, Tina, Groza, Tudor, Stiglic, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187991/
https://www.ncbi.nlm.nih.gov/pubmed/30345175
http://dx.doi.org/10.7717/peerj.5765
_version_ 1783363133233954816
author Kocbek, Simon
Kocbek, Primoz
Stozer, Andraz
Zupanic, Tina
Groza, Tudor
Stiglic, Gregor
author_facet Kocbek, Simon
Kocbek, Primoz
Stozer, Andraz
Zupanic, Tina
Groza, Tudor
Stiglic, Gregor
author_sort Kocbek, Simon
collection PubMed
description BACKGROUND: Multimorbidity presents an increasingly common problem in older population, and is tightly related to polypharmacy, i.e., concurrent use of multiple medications by one individual. Detecting polypharmacy from drug prescription records is not only related to multimorbidity, but can also point at incorrect use of medicines. In this work, we build models for predicting polypharmacy from drug prescription records for newly diagnosed chronic patients. We evaluate the models’ performance with a strong focus on interpretability of the results. METHODS: A centrally collected nationwide dataset of prescription records was used to perform electronic phenotyping of patients for the following two chronic conditions: type 2 diabetes mellitus (T2D) and cardiovascular disease (CVD). In addition, a hospital discharge dataset was linked to the prescription records. A regularized regression model was built for 11 different experimental scenarios on two datasets, and complexity of the model was controlled with a maximum number of dimensions (MND) parameter. Performance and interpretability of the model were evaluated with AUC, AUPRC, calibration plots, and interpretation by a medical doctor. RESULTS: For the CVD model, AUC and AUPRC values of 0.900 (95% [0.898–0.901]) and 0.640 (0.635–0.645) were reached, respectively, while for the T2D model the values were 0.808 (0.803–0.812) and 0.732 (0.725–0.739). Reducing complexity of the model by 65% and 48% for CVD and T2D, resulted in 3% and 4% lower AUC, and 4% and 5% lower AUPRC values, respectively. Calibration plots for our models showed that we can achieve moderate calibration with reducing the models’ complexity without significant loss of predictive performance. DISCUSSION: In this study, we found that it is possible to use drug prescription data to build a model for polypharmacy prediction in older population. In addition, the study showed that it is possible to find a balance between good performance and interpretability of the model, and achieve acceptable calibration at the same time.
format Online
Article
Text
id pubmed-6187991
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-61879912018-10-19 Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records Kocbek, Simon Kocbek, Primoz Stozer, Andraz Zupanic, Tina Groza, Tudor Stiglic, Gregor PeerJ Drugs and Devices BACKGROUND: Multimorbidity presents an increasingly common problem in older population, and is tightly related to polypharmacy, i.e., concurrent use of multiple medications by one individual. Detecting polypharmacy from drug prescription records is not only related to multimorbidity, but can also point at incorrect use of medicines. In this work, we build models for predicting polypharmacy from drug prescription records for newly diagnosed chronic patients. We evaluate the models’ performance with a strong focus on interpretability of the results. METHODS: A centrally collected nationwide dataset of prescription records was used to perform electronic phenotyping of patients for the following two chronic conditions: type 2 diabetes mellitus (T2D) and cardiovascular disease (CVD). In addition, a hospital discharge dataset was linked to the prescription records. A regularized regression model was built for 11 different experimental scenarios on two datasets, and complexity of the model was controlled with a maximum number of dimensions (MND) parameter. Performance and interpretability of the model were evaluated with AUC, AUPRC, calibration plots, and interpretation by a medical doctor. RESULTS: For the CVD model, AUC and AUPRC values of 0.900 (95% [0.898–0.901]) and 0.640 (0.635–0.645) were reached, respectively, while for the T2D model the values were 0.808 (0.803–0.812) and 0.732 (0.725–0.739). Reducing complexity of the model by 65% and 48% for CVD and T2D, resulted in 3% and 4% lower AUC, and 4% and 5% lower AUPRC values, respectively. Calibration plots for our models showed that we can achieve moderate calibration with reducing the models’ complexity without significant loss of predictive performance. DISCUSSION: In this study, we found that it is possible to use drug prescription data to build a model for polypharmacy prediction in older population. In addition, the study showed that it is possible to find a balance between good performance and interpretability of the model, and achieve acceptable calibration at the same time. PeerJ Inc. 2018-10-12 /pmc/articles/PMC6187991/ /pubmed/30345175 http://dx.doi.org/10.7717/peerj.5765 Text en ©2018 Kocbek et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Drugs and Devices
Kocbek, Simon
Kocbek, Primoz
Stozer, Andraz
Zupanic, Tina
Groza, Tudor
Stiglic, Gregor
Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
title Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
title_full Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
title_fullStr Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
title_full_unstemmed Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
title_short Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
title_sort building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
topic Drugs and Devices
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187991/
https://www.ncbi.nlm.nih.gov/pubmed/30345175
http://dx.doi.org/10.7717/peerj.5765
work_keys_str_mv AT kocbeksimon buildinginterpretablemodelsforpolypharmacypredictioninolderchronicpatientsbasedondrugprescriptionrecords
AT kocbekprimoz buildinginterpretablemodelsforpolypharmacypredictioninolderchronicpatientsbasedondrugprescriptionrecords
AT stozerandraz buildinginterpretablemodelsforpolypharmacypredictioninolderchronicpatientsbasedondrugprescriptionrecords
AT zupanictina buildinginterpretablemodelsforpolypharmacypredictioninolderchronicpatientsbasedondrugprescriptionrecords
AT grozatudor buildinginterpretablemodelsforpolypharmacypredictioninolderchronicpatientsbasedondrugprescriptionrecords
AT stiglicgregor buildinginterpretablemodelsforpolypharmacypredictioninolderchronicpatientsbasedondrugprescriptionrecords